RESECTABILITY OF COLORECTAL LIVER METASTASES (CLM) WITH CETUXIMAB PLUS CPT-11/5-FLUOROURACIL (5-FU)/LEUCOVORIN(FA)/OXALIPLATIN (L-OHP) (CPT-11-FFL) AS NEOADJUVANT TREATMENT (POCHER TRIAL)

被引：0
|
作者：
Torsello, A.
Garufi, C.
Tumolo, S.
Melucci, E.
Conti, S.
Campanella, C.
Zeuli, M.
Pizzi, G.
Tropea, G.
Sperduti, I
Ettorre, G. M.
Cognetti, F.
机构：
[1] Ist Regina Elena, I-00161 Rome, Italy
[2] Osped SM Angeli, Pordenone, Italy
[3] Osped S Camillo Roma, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial
    Z Saridaki
    N Androulakis
    N Vardakis
    L Vamvakas
    E Kabouraki
    K Kalbakis
    D Hatzidaki
    A Voutsina
    D Mavroudis
    V Georgoulias
    J Souglakos
    British Journal of Cancer, 2012, 107 : 1932 - 1937
  • [42] Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: A phase II trial
    Souglakos, J
    Pallis, A
    Kakolyris, S
    Mavroudis, D
    Androulakis, N
    Kouroussis, C
    Agelaki, S
    Xenidis, N
    Milaki, G
    Georgoulias, V
    ONCOLOGY, 2005, 69 (05) : 384 - 390
  • [43] A dose finding study of biweekly administration of irinotecan (CPT-11), 5-fluorouracil (5-FU) and levofolinic acid (I-LV) in colorectal cancer
    Casaretti, R
    Catalano, G
    Comella, P
    De Vita, F
    Avallone, V
    Gravina, A
    Orditura, M
    Comis, S
    Faranda, A
    Comella, G
    ANNALS OF ONCOLOGY, 1998, 9 : 68 - 68
  • [44] A bi-weekly schedule of irinotecan (CPT-11) and 5-fluorouracil (5-FU) in advanced colorectal cancer (ACRC): Phase I study.
    Morese, R
    Ricevuto, U
    Cannita, K
    Antonini, CGC
    Lanfiuti, BP
    Trapasso, T
    Porzio, G
    Marchetti, P
    Ficorella, C
    ANNALS OF ONCOLOGY, 2000, 11 : 71 - 71
  • [45] Folinic acid (FA) and 5-fluorouracil (FU) alone or with irinotecan (CPT-11) for advanced colorectal cancer (ACC): Preliminary results of a randomized phase II trial
    Maiello, E
    Giuliani, F
    Gebbia, V
    Cigolari, S
    Fortunato, S
    Paoletti, G
    Borsellino, N
    Lopez, M
    Gebbia, N
    Colucci, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S71 - S71
  • [46] Phase I-II study of bi-weekly irinotecan (CPT-11), oxaliplatin (LOHP), leucovorin (LV) and 5-fluorouracil (5-FU) 48 hrs continuous infusion in advanced colorectal cancer.
    Masi, G
    Falcone, A
    Allegrini, G
    Lencioni, M
    Pfanner, E
    Brunetti, I
    Galli, C
    Di Marsico, R
    Antonuzzo, A
    Conte, PF
    ANNALS OF ONCOLOGY, 2000, 11 : 70 - 70
  • [47] Addition of oxaliplatin (L-OHP(R)) to chronomodulated (CM) 5-fluorouracil (5-FU) and folinic acid (FA) for reversal of acquired chemoresistance in patients with advanced colorectal cancer (ACC)
    Garufi, C
    Bensmaine, MA
    Brienza, S
    Misset, JL
    Aschelter, A
    Pace, R
    BertheaultCvitkovic, F
    Terzoli, E
    Levi, F
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 124 - 124
  • [48] Whole body hyperthermia (WBH, 41.8°C) as an adjunct to oxaliplatin (OXA)/5-FU/FA in high-dose (HD)-5-FU/FA or HD-5-FU/FA and CPT-11 refractory/relapsed advanced colorectal cancer.
    Hegewisch-Becker, S
    Gruber, Y
    Panse, J
    Atanackovic, D
    Nierhaus, A
    Hossfeld, DK
    ANNALS OF ONCOLOGY, 2000, 11 : 61 - 61
  • [49] Alternating hepatic artery chronotherapy with CPT-11 and systemic chronotherapy with 5-FU/FA plus carboplatin for metastatic colorectal cancer confined to the liver: A phase II study
    Shimonov, M
    Hayat, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 297S - 297S
  • [50] Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trial
    Souglakos, J
    Syrigos, K
    Potamianou, A
    Polyzos, A
    Boukovinas, I
    Androulakis, N
    Kouroussis, C
    Vardakis, N
    Christophilakis, C
    Kotsakis, A
    Georgoulias, V
    ANNALS OF ONCOLOGY, 2004, 15 (08) : 1204 - 1209
12345